logo-loader
viewSensyne Health PLC

Sensyne Health present at the Proactive One2One virtual investment forum

Sensyne Health's (LON:SENS) Lord (Paul) Drayson pitches to investors at the Proactive One2One virtual investment forum.

Sensyne Health is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis and commercialisation of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts.

Quick facts: Sensyne Health PLC

Price: 150 GBX

AIM:SENS
Market: AIM
Market Cap: £192.86 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sensyne Health PLC named herein, including the promotion by the Company of Sensyne Health PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sensyne Health 'achieves primary IPO objective' with a database with over 5m...

Sensyne Health PLC's (LON:SENS) CEO Lord Paul Drayson talks to Proactive London's Katie Pilbeam about 'achieving their primary IPO objective' with a database over 5m records. This comes after its strategic research agreement with Somerset NHS Foundation Trust which pulls in 1.1mln unique...

1 week, 5 days ago

2 min read